[] [[Cozen O’Connor Letterhead] April 27, 2012 Skystar Bio-Pharmaceutical Company 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xi’an, Shaanxi Province, P.R. China Re: Registration Statement on Form S-8 In rendering this opinion, we have examined: (i) the Articles of Incorporation and By-laws of the Company, each as presently in effect; (ii) resolutions of the Company’s Board of] [Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Registration Statement on Form S-8 of Skystar Bio-Pharmaceutical Company of our report dated March 30, 2012 relating to the consolidated financial statements appearing in the Annual Report on Form 10-K of Skystar Bio-Pharmaceutical Company for the year ended December 31, 2011. Sherman Oaks, California]

[PART I INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS PARTII INFORMATION REQUIRED IN THE REGISTRATION STATEMENT Item 3.orporation of Documents by Reference. The following documents areorporated by reference in this Registration Statement: (a) Thempanys Annual Report on Form 10-K for the fiscal year ended December 31, 2011, filed with themmission on March 30, 2012;] [[Cozen OConnor Letterhead] April 27, 2012ystar Bio-Pharmaceuticalmpany 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xian, Shaanxi Province, P.R. China Re: Registration Statement on Form S-8 In rendering this opinion, we have examined: (i) the Articles oforporation and By-laws of thempany, each presently in effect; (ii) resolutions of thempanys Board of Directors] [Consent of Independent Registered Public Accounting Firm Wensent to theorporation by reference in this Registration Statement on Form S-8 ofystar Bio-Pharmaceuticalmpany of our reportted March 30, 2012 relating to thensolidated financial statements appearing in the Annual Report on Form 10-K ofystar Bio-Pharmaceuticalmpany for the year ended December 31, 2011.]